Biotechnology in the Time of COVID-19: Commentaries from the Front Line

by Jeremy M. Levin

George Scangos has been CEO of three biotechnology companies: VIR since January 2017, Biogen from 2010 through 2016, and Exelixis from 1996 to 2010.